/

Sunitinib

CAS 557795-19-4

Overview

Sunitinib is an oral, small-molecule, multi-targeted receptor tyrosine kinase inhibitor that was approved by the FDA for the treatment of renal cell carcinoma and imatinib-resistant gastrointestinal stromal tumor on January 26, 2006

Anant Labs manufacture and furnish high quality Sunitinib impurities for global markets. Our Sunitinib EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.

Active Pharmaceutical Ingredient

Chemical structure of Sunitinib

Sunitinib

CAS: 557795-19-4
Mol. Formula: C₂₂H₂₇FN₄O₂
Mol. Weight: 398.482

Impurities (6)

Chemical structure of Sunitinib Aldehyde Impurity

Sunitinib Aldehyde Impurity

Cat. No.: ANT-SNB-005
CAS: 356068-93-4
Mol. Formula: C₁₆H₁₃FN₂O₃
Mol. Weight: 300.28

Chemical structure of Sunitinib Des-Ethyl Impurity

Sunitinib Des-Ethyl Impurity

Cat. No.: ANT-SNB-006
CAS: 356068-97-8
Mol. Formula: C₂₀H₂₃FN₄O₂
Mol. Weight: 370.42

Chemical structure of Sunitinib Malate

Sunitinib Malate

Cat. No.: ANT-SNB-01
CAS: 341031-54-7
Mol. Formula: C₂₂H₂₇FN₄O₂.C₄H₆O₅
Mol. Weight: 532.569

Chemical structure of Sunitinib Malate Impurity D

Sunitinib Malate Impurity D

Cat. No.: ANT-SNB-02
CAS: 356068-86-5
Mol. Formula: C₁₄H₂₃N₃O₂
Mol. Weight: 265.36

Chemical structure of Sunitinib Malate Impurity F

Sunitinib Malate Impurity F

Cat. No.: ANT-SNB-04
CAS: 56341-41-4
Mol. Formula: C₈H₆FNO
Mol. Weight: 151.14

Chemical structure of Sunitinib N-Oxide

Sunitinib N-Oxide

Cat. No.: ANT-SNB-03
CAS: 356068-99-0
Mol. Formula: C₂₂H₂₇FN₄O₃
Mol. Weight: 414.47